About Alexis Borisy

Alexis Borisy, Founder, Chairman and Chief Executive Officer

As a leading biotechnology entrepreneur and investor with more than 25 years of experience building, operating and investing in innovative science-based companies, my goal is to make a positive difference in the world, now focusing on my latest venture: EQRx.

I’m the co-founder of Foundation Medicine and served as its first CEO, and then Chairman, where I remained on the Board of Directors until the $5 billion acquisition by Roche. I’ve also co-founded Blueprint Medicines, served as interim CEO, and continue to serve on its Board of Directors. As a Partner at Third Rock Ventures for a decade, I’m also a founding investor for Editas Medicine and Magenta Therapeutics, Revolution Medicines and Thrive Earlier Detection; a co-founder, former CEO, and Chairman of Relay Therapeutics; Chairman of Tango Therapeutics and Chairman of Celsius Therapeutics; and an investor in Insitro. I founded my first company, CombinatoRx, in 1999, where I served as CEO for 10 years. Additionally, I serve as Vice Chairman of the Board of Trustees of the Boston Museum of Science, and served on the Boards of the Biotechnology Innovation Organization and the National Venture Capital Association.

Interested in working at EQRx? We’re hiring—shoot me a message to learn more.